nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP1A2—Clobetasol propionate—psoriasis	0.128	0.226	CbGbCtD
Fluphenazine—CYP1A2—Methoxsalen—psoriasis	0.0672	0.119	CbGbCtD
Fluphenazine—CYP2D6—Hydroxyurea—psoriasis	0.0605	0.107	CbGbCtD
Fluphenazine—CYP2D6—Cholecalciferol—psoriasis	0.0367	0.0647	CbGbCtD
Fluphenazine—ABCB1—Mycophenolate mofetil—psoriasis	0.0337	0.0595	CbGbCtD
Fluphenazine—CYP2E1—Dexamethasone—psoriasis	0.0333	0.0587	CbGbCtD
Fluphenazine—ABCB1—Betamethasone—psoriasis	0.0289	0.0511	CbGbCtD
Fluphenazine—ABCB1—Prednisolone—psoriasis	0.0286	0.0504	CbGbCtD
Fluphenazine—ABCB1—Hydrocortisone—psoriasis	0.0271	0.0478	CbGbCtD
Fluphenazine—ABCB1—Prednisone—psoriasis	0.027	0.0476	CbGbCtD
Fluphenazine—ABCB1—Cyclosporine—psoriasis	0.0256	0.0451	CbGbCtD
Fluphenazine—CYP2D6—Cyclosporine—psoriasis	0.0241	0.0425	CbGbCtD
Fluphenazine—ABCB1—Dexamethasone—psoriasis	0.0168	0.0297	CbGbCtD
Fluphenazine—CYP2D6—Dexamethasone—psoriasis	0.0159	0.028	CbGbCtD
Fluphenazine—ABCB1—Methotrexate—psoriasis	0.0135	0.0239	CbGbCtD
Fluphenazine—Angioedema—Acitretin—psoriasis	0.000848	0.00279	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Cyclosporine—psoriasis	0.000847	0.00279	CcSEcCtD
Fluphenazine—Headache—Clobetasol propionate—psoriasis	0.000841	0.00277	CcSEcCtD
Fluphenazine—Lethargy—Cyclosporine—psoriasis	0.000837	0.00275	CcSEcCtD
Fluphenazine—Pancytopenia—Mycophenolic acid—psoriasis	0.000832	0.00274	CcSEcCtD
Fluphenazine—Skin disorder—Calcitriol—psoriasis	0.000827	0.00272	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Mycophenolic acid—psoriasis	0.000814	0.00268	CcSEcCtD
Fluphenazine—Disturbance in sexual arousal—Cyclosporine—psoriasis	0.000813	0.00268	CcSEcCtD
Fluphenazine—Eczema—Hydrocortisone—psoriasis	0.000811	0.00267	CcSEcCtD
Fluphenazine—Leukocytosis—Prednisone—psoriasis	0.000795	0.00262	CcSEcCtD
Fluphenazine—Pneumonia—Mycophenolic acid—psoriasis	0.000786	0.00259	CcSEcCtD
Fluphenazine—Dry mouth—Acitretin—psoriasis	0.000773	0.00254	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Prednisolone—psoriasis	0.000771	0.00254	CcSEcCtD
Fluphenazine—Headache—Beclomethasone—psoriasis	0.000765	0.00252	CcSEcCtD
Fluphenazine—Cardiac arrest—Mycophenolate mofetil—psoriasis	0.000761	0.0025	CcSEcCtD
Fluphenazine—Urticaria—Methoxsalen—psoriasis	0.000759	0.0025	CcSEcCtD
Fluphenazine—Headache—Fluocinonide—psoriasis	0.000758	0.0025	CcSEcCtD
Fluphenazine—Somnolence—Calcitriol—psoriasis	0.000757	0.00249	CcSEcCtD
Fluphenazine—Body temperature increased—Methoxsalen—psoriasis	0.000755	0.00249	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Hydrocortisone—psoriasis	0.000753	0.00248	CcSEcCtD
Fluphenazine—Lethargy—Hydrocortisone—psoriasis	0.000744	0.00245	CcSEcCtD
Fluphenazine—Decreased appetite—Calcitriol—psoriasis	0.00074	0.00244	CcSEcCtD
Fluphenazine—Skin disorder—Acitretin—psoriasis	0.000736	0.00242	CcSEcCtD
Fluphenazine—Agranulocytosis—Mycophenolic acid—psoriasis	0.000729	0.0024	CcSEcCtD
Fluphenazine—Erythema—Hydroxyurea—psoriasis	0.000729	0.0024	CcSEcCtD
Fluphenazine—Constipation—Calcitriol—psoriasis	0.000728	0.0024	CcSEcCtD
Fluphenazine—Nausea—Beclomethasone—psoriasis	0.000726	0.00239	CcSEcCtD
Fluphenazine—Cardiac arrest—Prednisolone—psoriasis	0.000709	0.00234	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Triamcinolone—psoriasis	0.000709	0.00233	CcSEcCtD
Fluphenazine—Dysphagia—Cyclosporine—psoriasis	0.000709	0.00233	CcSEcCtD
Fluphenazine—Hypersensitivity—Methoxsalen—psoriasis	0.000704	0.00232	CcSEcCtD
Fluphenazine—Cardiac arrest—Hydrocortisone—psoriasis	0.000693	0.00228	CcSEcCtD
Fluphenazine—Asthma—Mycophenolate mofetil—psoriasis	0.000691	0.00228	CcSEcCtD
Fluphenazine—Dysphagia—Mycophenolate mofetil—psoriasis	0.000691	0.00228	CcSEcCtD
Fluphenazine—Oedema peripheral—Mycophenolic acid—psoriasis	0.000691	0.00227	CcSEcCtD
Fluphenazine—Urticaria—Calcitriol—psoriasis	0.000677	0.00223	CcSEcCtD
Fluphenazine—Pruritus—Methoxsalen—psoriasis	0.000676	0.00223	CcSEcCtD
Fluphenazine—Somnolence—Acitretin—psoriasis	0.000673	0.00222	CcSEcCtD
Fluphenazine—Body temperature increased—Calcitriol—psoriasis	0.000673	0.00222	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Cyclosporine—psoriasis	0.000659	0.00217	CcSEcCtD
Fluphenazine—Decreased appetite—Acitretin—psoriasis	0.000659	0.00217	CcSEcCtD
Fluphenazine—Pancytopenia—Mycophenolate mofetil—psoriasis	0.000657	0.00216	CcSEcCtD
Fluphenazine—Cardiac arrest—Triamcinolone—psoriasis	0.000652	0.00215	CcSEcCtD
Fluphenazine—Leukopenia—Hydroxyurea—psoriasis	0.000652	0.00215	CcSEcCtD
Fluphenazine—Constipation—Acitretin—psoriasis	0.000648	0.00213	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Dexamethasone—psoriasis	0.000643	0.00212	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Betamethasone—psoriasis	0.000643	0.00212	CcSEcCtD
Fluphenazine—Pneumonia—Cyclosporine—psoriasis	0.000636	0.00209	CcSEcCtD
Fluphenazine—Lethargy—Dexamethasone—psoriasis	0.000635	0.00209	CcSEcCtD
Fluphenazine—Lethargy—Betamethasone—psoriasis	0.000635	0.00209	CcSEcCtD
Fluphenazine—Hypersensitivity—Calcitriol—psoriasis	0.000627	0.00207	CcSEcCtD
Fluphenazine—Pneumonia—Mycophenolate mofetil—psoriasis	0.00062	0.00204	CcSEcCtD
Fluphenazine—Pruritus—Calcitriol—psoriasis	0.000602	0.00198	CcSEcCtD
Fluphenazine—Urticaria—Acitretin—psoriasis	0.000602	0.00198	CcSEcCtD
Fluphenazine—Body temperature increased—Acitretin—psoriasis	0.000599	0.00197	CcSEcCtD
Fluphenazine—Headache—Methoxsalen—psoriasis	0.000599	0.00197	CcSEcCtD
Fluphenazine—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.000597	0.00197	CcSEcCtD
Fluphenazine—Asthma—Triamcinolone—psoriasis	0.000593	0.00195	CcSEcCtD
Fluphenazine—Cardiac arrest—Dexamethasone—psoriasis	0.000592	0.00195	CcSEcCtD
Fluphenazine—Cardiac arrest—Betamethasone—psoriasis	0.000592	0.00195	CcSEcCtD
Fluphenazine—Muscle spasms—Mycophenolic acid—psoriasis	0.000587	0.00193	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Hydrocortisone—psoriasis	0.000585	0.00193	CcSEcCtD
Fluphenazine—Skin disorder—Hydroxyurea—psoriasis	0.000578	0.0019	CcSEcCtD
Fluphenazine—Vision blurred—Mycophenolic acid—psoriasis	0.000575	0.00189	CcSEcCtD
Fluphenazine—Agranulocytosis—Mycophenolate mofetil—psoriasis	0.000575	0.00189	CcSEcCtD
Fluphenazine—Nausea—Methoxsalen—psoriasis	0.000568	0.00187	CcSEcCtD
Fluphenazine—Urine output increased—Methotrexate—psoriasis	0.000564	0.00186	CcSEcCtD
Fluphenazine—Agitation—Mycophenolic acid—psoriasis	0.000561	0.00185	CcSEcCtD
Fluphenazine—Gynaecomastia—Methotrexate—psoriasis	0.000559	0.00184	CcSEcCtD
Fluphenazine—Hypersensitivity—Acitretin—psoriasis	0.000558	0.00184	CcSEcCtD
Fluphenazine—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000557	0.00183	CcSEcCtD
Fluphenazine—Lethargy—Prednisone—psoriasis	0.000553	0.00182	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Triamcinolone—psoriasis	0.000551	0.00181	CcSEcCtD
Fluphenazine—Leukopenia—Mycophenolic acid—psoriasis	0.000546	0.0018	CcSEcCtD
Fluphenazine—Oedema peripheral—Mycophenolate mofetil—psoriasis	0.000545	0.00179	CcSEcCtD
Fluphenazine—Pruritus—Acitretin—psoriasis	0.000536	0.00176	CcSEcCtD
Fluphenazine—Pruritus—Fluocinolone Acetonide—psoriasis	0.000534	0.00176	CcSEcCtD
Fluphenazine—Headache—Calcitriol—psoriasis	0.000533	0.00176	CcSEcCtD
Fluphenazine—Dyspnoea—Hydroxyurea—psoriasis	0.00053	0.00175	CcSEcCtD
Fluphenazine—Somnolence—Hydroxyurea—psoriasis	0.000529	0.00174	CcSEcCtD
Fluphenazine—Hypertension—Mycophenolic acid—psoriasis	0.000527	0.00173	CcSEcCtD
Fluphenazine—Decreased appetite—Hydroxyurea—psoriasis	0.000517	0.0017	CcSEcCtD
Fluphenazine—Photosensitivity—Methotrexate—psoriasis	0.000516	0.0017	CcSEcCtD
Fluphenazine—Polyuria—Methotrexate—psoriasis	0.000516	0.0017	CcSEcCtD
Fluphenazine—Cardiac arrest—Prednisone—psoriasis	0.000516	0.0017	CcSEcCtD
Fluphenazine—Constipation—Hydroxyurea—psoriasis	0.000509	0.00167	CcSEcCtD
Fluphenazine—Dry mouth—Mycophenolic acid—psoriasis	0.000508	0.00167	CcSEcCtD
Fluphenazine—Nausea—Calcitriol—psoriasis	0.000506	0.00167	CcSEcCtD
Fluphenazine—Renal failure acute—Methotrexate—psoriasis	0.000491	0.00162	CcSEcCtD
Fluphenazine—Tachycardia—Mycophenolic acid—psoriasis	0.000486	0.0016	CcSEcCtD
Fluphenazine—Skin disorder—Mycophenolic acid—psoriasis	0.000484	0.00159	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Methotrexate—psoriasis	0.00048	0.00158	CcSEcCtD
Fluphenazine—Muscle spasms—Cyclosporine—psoriasis	0.000475	0.00156	CcSEcCtD
Fluphenazine—Headache—Acitretin—psoriasis	0.000475	0.00156	CcSEcCtD
Fluphenazine—Headache—Fluocinolone Acetonide—psoriasis	0.000473	0.00156	CcSEcCtD
Fluphenazine—Body temperature increased—Hydroxyurea—psoriasis	0.00047	0.00155	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Methotrexate—psoriasis	0.000468	0.00154	CcSEcCtD
Fluphenazine—Hypotension—Mycophenolic acid—psoriasis	0.000465	0.00153	CcSEcCtD
Fluphenazine—Vision blurred—Cyclosporine—psoriasis	0.000465	0.00153	CcSEcCtD
Fluphenazine—Muscle spasms—Mycophenolate mofetil—psoriasis	0.000463	0.00152	CcSEcCtD
Fluphenazine—Lethargy—Methotrexate—psoriasis	0.000462	0.00152	CcSEcCtD
Fluphenazine—Agitation—Cyclosporine—psoriasis	0.000454	0.00149	CcSEcCtD
Fluphenazine—Angioedema—Cyclosporine—psoriasis	0.000451	0.00149	CcSEcCtD
Fluphenazine—Nausea—Acitretin—psoriasis	0.00045	0.00148	CcSEcCtD
Fluphenazine—Erythema—Prednisolone—psoriasis	0.000449	0.00148	CcSEcCtD
Fluphenazine—Nausea—Fluocinolone Acetonide—psoriasis	0.000449	0.00148	CcSEcCtD
Fluphenazine—Dyspnoea—Mycophenolic acid—psoriasis	0.000444	0.00146	CcSEcCtD
Fluphenazine—Somnolence—Mycophenolic acid—psoriasis	0.000443	0.00146	CcSEcCtD
Fluphenazine—Agitation—Mycophenolate mofetil—psoriasis	0.000443	0.00146	CcSEcCtD
Fluphenazine—Leukopenia—Cyclosporine—psoriasis	0.000442	0.00145	CcSEcCtD
Fluphenazine—Angioedema—Mycophenolate mofetil—psoriasis	0.00044	0.00145	CcSEcCtD
Fluphenazine—Erythema—Hydrocortisone—psoriasis	0.000439	0.00144	CcSEcCtD
Fluphenazine—Hypersensitivity—Hydroxyurea—psoriasis	0.000438	0.00144	CcSEcCtD
Fluphenazine—Decreased appetite—Mycophenolic acid—psoriasis	0.000433	0.00143	CcSEcCtD
Fluphenazine—Leukopenia—Mycophenolate mofetil—psoriasis	0.000431	0.00142	CcSEcCtD
Fluphenazine—Hypertension—Cyclosporine—psoriasis	0.000426	0.0014	CcSEcCtD
Fluphenazine—Constipation—Mycophenolic acid—psoriasis	0.000426	0.0014	CcSEcCtD
Fluphenazine—Vision blurred—Prednisolone—psoriasis	0.000423	0.00139	CcSEcCtD
Fluphenazine—Hypertension—Mycophenolate mofetil—psoriasis	0.000416	0.00137	CcSEcCtD
Fluphenazine—Erythema—Triamcinolone—psoriasis	0.000413	0.00136	CcSEcCtD
Fluphenazine—Dry mouth—Cyclosporine—psoriasis	0.000411	0.00135	CcSEcCtD
Fluphenazine—Angioedema—Prednisolone—psoriasis	0.000411	0.00135	CcSEcCtD
Fluphenazine—Anaphylactic shock—Cyclosporine—psoriasis	0.000403	0.00133	CcSEcCtD
Fluphenazine—Dry mouth—Mycophenolate mofetil—psoriasis	0.000401	0.00132	CcSEcCtD
Fluphenazine—Angioedema—Hydrocortisone—psoriasis	0.000401	0.00132	CcSEcCtD
Fluphenazine—Body temperature increased—Mycophenolic acid—psoriasis	0.000394	0.0013	CcSEcCtD
Fluphenazine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000393	0.00129	CcSEcCtD
Fluphenazine—Asthma—Methotrexate—psoriasis	0.000392	0.00129	CcSEcCtD
Fluphenazine—Skin disorder—Cyclosporine—psoriasis	0.000391	0.00129	CcSEcCtD
Fluphenazine—Hypertension—Prednisolone—psoriasis	0.000388	0.00128	CcSEcCtD
Fluphenazine—Eosinophilia—Methotrexate—psoriasis	0.000388	0.00128	CcSEcCtD
Fluphenazine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000384	0.00126	CcSEcCtD
Fluphenazine—Skin disorder—Mycophenolate mofetil—psoriasis	0.000382	0.00126	CcSEcCtD
Fluphenazine—Hypertension—Hydrocortisone—psoriasis	0.000379	0.00125	CcSEcCtD
Fluphenazine—Angioedema—Triamcinolone—psoriasis	0.000378	0.00124	CcSEcCtD
Fluphenazine—Erythema—Betamethasone—psoriasis	0.000375	0.00123	CcSEcCtD
Fluphenazine—Erythema—Dexamethasone—psoriasis	0.000375	0.00123	CcSEcCtD
Fluphenazine—Headache—Hydroxyurea—psoriasis	0.000373	0.00123	CcSEcCtD
Fluphenazine—Pancytopenia—Methotrexate—psoriasis	0.000372	0.00122	CcSEcCtD
Fluphenazine—Hypotension—Mycophenolate mofetil—psoriasis	0.000367	0.00121	CcSEcCtD
Fluphenazine—Anaphylactic shock—Prednisolone—psoriasis	0.000367	0.00121	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Methotrexate—psoriasis	0.000364	0.0012	CcSEcCtD
Fluphenazine—Dyspnoea—Cyclosporine—psoriasis	0.000359	0.00118	CcSEcCtD
Fluphenazine—Somnolence—Cyclosporine—psoriasis	0.000358	0.00118	CcSEcCtD
Fluphenazine—Anaphylactic shock—Hydrocortisone—psoriasis	0.000358	0.00118	CcSEcCtD
Fluphenazine—Tachycardia—Prednisolone—psoriasis	0.000358	0.00118	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Methotrexate—psoriasis	0.000357	0.00118	CcSEcCtD
Fluphenazine—Hypertension—Triamcinolone—psoriasis	0.000357	0.00117	CcSEcCtD
Fluphenazine—Nausea—Hydroxyurea—psoriasis	0.000353	0.00116	CcSEcCtD
Fluphenazine—Pruritus—Mycophenolic acid—psoriasis	0.000352	0.00116	CcSEcCtD
Fluphenazine—Pneumonia—Methotrexate—psoriasis	0.000351	0.00116	CcSEcCtD
Fluphenazine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.00035	0.00115	CcSEcCtD
Fluphenazine—Decreased appetite—Cyclosporine—psoriasis	0.00035	0.00115	CcSEcCtD
Fluphenazine—Tachycardia—Hydrocortisone—psoriasis	0.00035	0.00115	CcSEcCtD
Fluphenazine—Somnolence—Mycophenolate mofetil—psoriasis	0.000349	0.00115	CcSEcCtD
Fluphenazine—Drowsiness—Methotrexate—psoriasis	0.000349	0.00115	CcSEcCtD
Fluphenazine—Skin disorder—Hydrocortisone—psoriasis	0.000348	0.00115	CcSEcCtD
Fluphenazine—Constipation—Cyclosporine—psoriasis	0.000345	0.00113	CcSEcCtD
Fluphenazine—Dry mouth—Triamcinolone—psoriasis	0.000344	0.00113	CcSEcCtD
Fluphenazine—Angioedema—Betamethasone—psoriasis	0.000343	0.00113	CcSEcCtD
Fluphenazine—Angioedema—Dexamethasone—psoriasis	0.000343	0.00113	CcSEcCtD
Fluphenazine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000342	0.00112	CcSEcCtD
Fluphenazine—Anaphylactic shock—Triamcinolone—psoriasis	0.000337	0.00111	CcSEcCtD
Fluphenazine—Constipation—Mycophenolate mofetil—psoriasis	0.000336	0.00111	CcSEcCtD
Fluphenazine—Hypotension—Hydrocortisone—psoriasis	0.000335	0.0011	CcSEcCtD
Fluphenazine—Tachycardia—Triamcinolone—psoriasis	0.000329	0.00108	CcSEcCtD
Fluphenazine—Erythema—Prednisone—psoriasis	0.000327	0.00107	CcSEcCtD
Fluphenazine—Agranulocytosis—Methotrexate—psoriasis	0.000326	0.00107	CcSEcCtD
Fluphenazine—Hypertension—Dexamethasone—psoriasis	0.000324	0.00107	CcSEcCtD
Fluphenazine—Hypertension—Betamethasone—psoriasis	0.000324	0.00107	CcSEcCtD
Fluphenazine—Urticaria—Cyclosporine—psoriasis	0.00032	0.00105	CcSEcCtD
Fluphenazine—Body temperature increased—Cyclosporine—psoriasis	0.000319	0.00105	CcSEcCtD
Fluphenazine—Urticaria—Mycophenolate mofetil—psoriasis	0.000312	0.00103	CcSEcCtD
Fluphenazine—Headache—Mycophenolic acid—psoriasis	0.000312	0.00103	CcSEcCtD
Fluphenazine—Decreased appetite—Hydrocortisone—psoriasis	0.000311	0.00102	CcSEcCtD
Fluphenazine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000311	0.00102	CcSEcCtD
Fluphenazine—Vision blurred—Prednisone—psoriasis	0.000308	0.00101	CcSEcCtD
Fluphenazine—Anaphylactic shock—Dexamethasone—psoriasis	0.000306	0.00101	CcSEcCtD
Fluphenazine—Anaphylactic shock—Betamethasone—psoriasis	0.000306	0.00101	CcSEcCtD
Fluphenazine—Dyspnoea—Triamcinolone—psoriasis	0.000301	0.00099	CcSEcCtD
Fluphenazine—Agitation—Prednisone—psoriasis	0.0003	0.000988	CcSEcCtD
Fluphenazine—Tachycardia—Dexamethasone—psoriasis	0.000299	0.000983	CcSEcCtD
Fluphenazine—Tachycardia—Betamethasone—psoriasis	0.000299	0.000983	CcSEcCtD
Fluphenazine—Angioedema—Prednisone—psoriasis	0.000298	0.000982	CcSEcCtD
Fluphenazine—Hypersensitivity—Cyclosporine—psoriasis	0.000297	0.000977	CcSEcCtD
Fluphenazine—Nausea—Mycophenolic acid—psoriasis	0.000296	0.000974	CcSEcCtD
Fluphenazine—Urticaria—Prednisolone—psoriasis	0.000291	0.000959	CcSEcCtD
Fluphenazine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.00029	0.000953	CcSEcCtD
Fluphenazine—Hypotension—Dexamethasone—psoriasis	0.000286	0.000941	CcSEcCtD
Fluphenazine—Hypotension—Betamethasone—psoriasis	0.000286	0.000941	CcSEcCtD
Fluphenazine—Pruritus—Cyclosporine—psoriasis	0.000285	0.000939	CcSEcCtD
Fluphenazine—Urticaria—Hydrocortisone—psoriasis	0.000285	0.000937	CcSEcCtD
Fluphenazine—Body temperature increased—Hydrocortisone—psoriasis	0.000283	0.000932	CcSEcCtD
Fluphenazine—Hypertension—Prednisone—psoriasis	0.000282	0.000928	CcSEcCtD
Fluphenazine—Pruritus—Mycophenolate mofetil—psoriasis	0.000278	0.000916	CcSEcCtD
Fluphenazine—Erythema—Methotrexate—psoriasis	0.000273	0.000898	CcSEcCtD
Fluphenazine—Hypersensitivity—Prednisolone—psoriasis	0.00027	0.000889	CcSEcCtD
Fluphenazine—Urticaria—Triamcinolone—psoriasis	0.000268	0.000882	CcSEcCtD
Fluphenazine—Body temperature increased—Triamcinolone—psoriasis	0.000267	0.000878	CcSEcCtD
Fluphenazine—Anaphylactic shock—Prednisone—psoriasis	0.000266	0.000877	CcSEcCtD
Fluphenazine—Decreased appetite—Dexamethasone—psoriasis	0.000266	0.000876	CcSEcCtD
Fluphenazine—Decreased appetite—Betamethasone—psoriasis	0.000266	0.000876	CcSEcCtD
Fluphenazine—Hypersensitivity—Hydrocortisone—psoriasis	0.000264	0.000869	CcSEcCtD
Fluphenazine—Tachycardia—Prednisone—psoriasis	0.00026	0.000856	CcSEcCtD
Fluphenazine—Skin disorder—Prednisone—psoriasis	0.000259	0.000852	CcSEcCtD
Fluphenazine—Vision blurred—Methotrexate—psoriasis	0.000257	0.000847	CcSEcCtD
Fluphenazine—Pruritus—Hydrocortisone—psoriasis	0.000253	0.000834	CcSEcCtD
Fluphenazine—Headache—Cyclosporine—psoriasis	0.000252	0.000831	CcSEcCtD
Fluphenazine—Hypersensitivity—Triamcinolone—psoriasis	0.000248	0.000818	CcSEcCtD
Fluphenazine—Headache—Mycophenolate mofetil—psoriasis	0.000246	0.000811	CcSEcCtD
Fluphenazine—Leukopenia—Methotrexate—psoriasis	0.000244	0.000804	CcSEcCtD
Fluphenazine—Urticaria—Dexamethasone—psoriasis	0.000243	0.0008	CcSEcCtD
Fluphenazine—Urticaria—Betamethasone—psoriasis	0.000243	0.0008	CcSEcCtD
Fluphenazine—Body temperature increased—Betamethasone—psoriasis	0.000242	0.000796	CcSEcCtD
Fluphenazine—Body temperature increased—Dexamethasone—psoriasis	0.000242	0.000796	CcSEcCtD
Fluphenazine—Nausea—Cyclosporine—psoriasis	0.000239	0.000788	CcSEcCtD
Fluphenazine—Pruritus—Triamcinolone—psoriasis	0.000239	0.000785	CcSEcCtD
Fluphenazine—Nausea—Mycophenolate mofetil—psoriasis	0.000234	0.000769	CcSEcCtD
Fluphenazine—Decreased appetite—Prednisone—psoriasis	0.000232	0.000763	CcSEcCtD
Fluphenazine—Headache—Prednisolone—psoriasis	0.00023	0.000756	CcSEcCtD
Fluphenazine—Constipation—Prednisone—psoriasis	0.000228	0.00075	CcSEcCtD
Fluphenazine—Headache—Hydrocortisone—psoriasis	0.000224	0.000739	CcSEcCtD
Fluphenazine—Anaphylactic shock—Methotrexate—psoriasis	0.000223	0.000733	CcSEcCtD
Fluphenazine—Nausea—Prednisolone—psoriasis	0.000218	0.000717	CcSEcCtD
Fluphenazine—Pruritus—Dexamethasone—psoriasis	0.000216	0.000713	CcSEcCtD
Fluphenazine—Pruritus—Betamethasone—psoriasis	0.000216	0.000713	CcSEcCtD
Fluphenazine—Skin disorder—Methotrexate—psoriasis	0.000216	0.000712	CcSEcCtD
Fluphenazine—Nausea—Hydrocortisone—psoriasis	0.000213	0.0007	CcSEcCtD
Fluphenazine—Urticaria—Prednisone—psoriasis	0.000212	0.000697	CcSEcCtD
Fluphenazine—Headache—Triamcinolone—psoriasis	0.000211	0.000695	CcSEcCtD
Fluphenazine—Body temperature increased—Prednisone—psoriasis	0.000211	0.000693	CcSEcCtD
Fluphenazine—Hypotension—Methotrexate—psoriasis	0.000208	0.000685	CcSEcCtD
Fluphenazine—Nausea—Triamcinolone—psoriasis	0.0002	0.000659	CcSEcCtD
Fluphenazine—Dyspnoea—Methotrexate—psoriasis	0.000199	0.000654	CcSEcCtD
Fluphenazine—Somnolence—Methotrexate—psoriasis	0.000198	0.000652	CcSEcCtD
Fluphenazine—Hypersensitivity—Prednisone—psoriasis	0.000196	0.000646	CcSEcCtD
Fluphenazine—Decreased appetite—Methotrexate—psoriasis	0.000194	0.000637	CcSEcCtD
Fluphenazine—Headache—Dexamethasone—psoriasis	0.000192	0.000631	CcSEcCtD
Fluphenazine—Headache—Betamethasone—psoriasis	0.000192	0.000631	CcSEcCtD
Fluphenazine—Pruritus—Prednisone—psoriasis	0.000189	0.000621	CcSEcCtD
Fluphenazine—Nausea—Betamethasone—psoriasis	0.000182	0.000598	CcSEcCtD
Fluphenazine—Nausea—Dexamethasone—psoriasis	0.000182	0.000598	CcSEcCtD
Fluphenazine—Urticaria—Methotrexate—psoriasis	0.000177	0.000582	CcSEcCtD
Fluphenazine—Body temperature increased—Methotrexate—psoriasis	0.000176	0.00058	CcSEcCtD
Fluphenazine—Headache—Prednisone—psoriasis	0.000167	0.00055	CcSEcCtD
Fluphenazine—Hypersensitivity—Methotrexate—psoriasis	0.000164	0.00054	CcSEcCtD
Fluphenazine—Nausea—Prednisone—psoriasis	0.000158	0.000521	CcSEcCtD
Fluphenazine—Pruritus—Methotrexate—psoriasis	0.000158	0.000519	CcSEcCtD
Fluphenazine—Headache—Methotrexate—psoriasis	0.00014	0.000459	CcSEcCtD
Fluphenazine—Nausea—Methotrexate—psoriasis	0.000132	0.000435	CcSEcCtD
Fluphenazine—HTR2A—Signaling by GPCR—TYK2—psoriasis	2.39e-05	0.000184	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—TYK2—psoriasis	2.38e-05	0.000184	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—CAT—psoriasis	2.38e-05	0.000183	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—VEGFA—psoriasis	2.36e-05	0.000182	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—VEGFA—psoriasis	2.36e-05	0.000182	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—CAT—psoriasis	2.36e-05	0.000182	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HLA-A—psoriasis	2.35e-05	0.000181	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CRP—psoriasis	2.34e-05	0.000181	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CRP—psoriasis	2.34e-05	0.000181	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—NFKB1—psoriasis	2.34e-05	0.000181	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—NFKB1—psoriasis	2.34e-05	0.000181	CbGpPWpGaD
Fluphenazine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	2.33e-05	0.000179	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—NFKB1—psoriasis	2.33e-05	0.000179	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CARM1—psoriasis	2.32e-05	0.000179	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HLA-DRB1—psoriasis	2.32e-05	0.000179	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—NFKBIA—psoriasis	2.32e-05	0.000179	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	2.29e-05	0.000177	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—NFKBIA—psoriasis	2.29e-05	0.000176	CbGpPWpGaD
Fluphenazine—HRH1—GPCR downstream signaling—CXCL8—psoriasis	2.28e-05	0.000176	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—CAT—psoriasis	2.28e-05	0.000176	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—CAT—psoriasis	2.28e-05	0.000176	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	2.28e-05	0.000176	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HLA-A—psoriasis	2.27e-05	0.000175	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HLA-A—psoriasis	2.27e-05	0.000175	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—NFKB1—psoriasis	2.25e-05	0.000174	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—NFKB1—psoriasis	2.25e-05	0.000174	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HLA-DRB1—psoriasis	2.25e-05	0.000173	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HLA-DRB1—psoriasis	2.25e-05	0.000173	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—ICAM1—psoriasis	2.23e-05	0.000172	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—NFKBIA—psoriasis	2.21e-05	0.000171	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TYK2—psoriasis	2.2e-05	0.00017	CbGpPWpGaD
Fluphenazine—CALM3—Disease—APOE—psoriasis	2.19e-05	0.000169	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	2.17e-05	0.000168	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.17e-05	0.000167	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—ICAM1—psoriasis	2.16e-05	0.000166	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—ICAM1—psoriasis	2.16e-05	0.000166	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—APOE—psoriasis	2.14e-05	0.000165	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—LEP—psoriasis	2.14e-05	0.000165	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—NFKBIA—psoriasis	2.14e-05	0.000165	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—NFKBIA—psoriasis	2.14e-05	0.000165	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—LEP—psoriasis	2.13e-05	0.000164	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—APOE—psoriasis	2.13e-05	0.000164	CbGpPWpGaD
Fluphenazine—CALM2—Disease—APOE—psoriasis	2.12e-05	0.000163	CbGpPWpGaD
Fluphenazine—CALM1—Disease—APOE—psoriasis	2.12e-05	0.000163	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—CXCL8—psoriasis	2.11e-05	0.000163	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	2.08e-05	0.000161	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	2.08e-05	0.00016	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SOCS1—psoriasis	2.08e-05	0.00016	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—CXCL8—psoriasis	2.07e-05	0.00016	CbGpPWpGaD
Fluphenazine—CALM3—Disease—NOS2—psoriasis	2.04e-05	0.000157	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—TP53—psoriasis	2.02e-05	0.000156	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SOCS1—psoriasis	2.01e-05	0.000155	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SOCS1—psoriasis	2.01e-05	0.000155	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—APOE—psoriasis	2.01e-05	0.000155	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	1.99e-05	0.000154	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	1.98e-05	0.000153	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—TYK2—psoriasis	1.98e-05	0.000153	CbGpPWpGaD
Fluphenazine—CALM2—Disease—NOS2—psoriasis	1.97e-05	0.000152	CbGpPWpGaD
Fluphenazine—CALM1—Disease—NOS2—psoriasis	1.97e-05	0.000152	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—CXCL8—psoriasis	1.92e-05	0.000148	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—TYK2—psoriasis	1.92e-05	0.000148	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—TYK2—psoriasis	1.92e-05	0.000148	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TYK2—psoriasis	1.9e-05	0.000146	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	1.89e-05	0.000146	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—APOE—psoriasis	1.88e-05	0.000145	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—LEP—psoriasis	1.88e-05	0.000145	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TYK2—psoriasis	1.87e-05	0.000145	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—LEP—psoriasis	1.85e-05	0.000143	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—APOE—psoriasis	1.85e-05	0.000143	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—APOE—psoriasis	1.85e-05	0.000142	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—TP53—psoriasis	1.84e-05	0.000142	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—APOE—psoriasis	1.84e-05	0.000142	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—LEP—psoriasis	1.84e-05	0.000142	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—APOE—psoriasis	1.83e-05	0.000142	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—IL6—psoriasis	1.83e-05	0.000141	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—TYK2—psoriasis	1.81e-05	0.00014	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—CAT—psoriasis	1.79e-05	0.000138	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—JUN—psoriasis	1.78e-05	0.000138	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—TP53—psoriasis	1.78e-05	0.000138	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—TP53—psoriasis	1.78e-05	0.000138	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—APOE—psoriasis	1.77e-05	0.000137	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—APOE—psoriasis	1.77e-05	0.000137	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—TYK2—psoriasis	1.75e-05	0.000135	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—TYK2—psoriasis	1.75e-05	0.000135	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PPARG—psoriasis	1.75e-05	0.000135	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NFKBIA—psoriasis	1.75e-05	0.000135	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—CXCL8—psoriasis	1.73e-05	0.000133	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	1.72e-05	0.000133	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—NFKB1—psoriasis	1.72e-05	0.000133	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NFKBIA—psoriasis	1.72e-05	0.000133	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IFNG—psoriasis	1.7e-05	0.000131	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—CAT—psoriasis	1.69e-05	0.00013	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—LEP—psoriasis	1.68e-05	0.00013	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—APOE—psoriasis	1.68e-05	0.00013	CbGpPWpGaD
Fluphenazine—CALM3—Disease—TYK2—psoriasis	1.67e-05	0.000129	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—CXCL8—psoriasis	1.67e-05	0.000129	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—CXCL8—psoriasis	1.67e-05	0.000129	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CXCL8—psoriasis	1.65e-05	0.000128	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IFNG—psoriasis	1.64e-05	0.000127	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IFNG—psoriasis	1.64e-05	0.000127	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CD4—psoriasis	1.64e-05	0.000126	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TYK2—psoriasis	1.63e-05	0.000126	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CXCL8—psoriasis	1.63e-05	0.000126	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TYK2—psoriasis	1.62e-05	0.000125	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TYK2—psoriasis	1.62e-05	0.000125	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TYK2—psoriasis	1.62e-05	0.000125	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PPARG—psoriasis	1.61e-05	0.000124	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PPARG—psoriasis	1.6e-05	0.000123	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CD4—psoriasis	1.58e-05	0.000122	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CD4—psoriasis	1.58e-05	0.000122	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—IL6—psoriasis	1.57e-05	0.000121	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	1.57e-05	0.000121	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—VEGFA—psoriasis	1.56e-05	0.00012	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—IL6—psoriasis	1.55e-05	0.00012	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PPARG—psoriasis	1.55e-05	0.000119	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PPARG—psoriasis	1.55e-05	0.000119	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—STAT3—psoriasis	1.54e-05	0.000119	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—JUN—psoriasis	1.54e-05	0.000119	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—APOE—psoriasis	1.53e-05	0.000118	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—LEP—psoriasis	1.53e-05	0.000118	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—IL6—psoriasis	1.52e-05	0.000117	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—JUN—psoriasis	1.52e-05	0.000117	CbGpPWpGaD
Fluphenazine—CALM3—Disease—CD4—psoriasis	1.51e-05	0.000117	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—APOE—psoriasis	1.48e-05	0.000114	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—LEP—psoriasis	1.48e-05	0.000114	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—LEP—psoriasis	1.48e-05	0.000114	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—APOE—psoriasis	1.48e-05	0.000114	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—NFKB1—psoriasis	1.48e-05	0.000114	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—IL6—psoriasis	1.47e-05	0.000113	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—IL6—psoriasis	1.47e-05	0.000113	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—JUN—psoriasis	1.47e-05	0.000113	CbGpPWpGaD
Fluphenazine—CALM1—Disease—CD4—psoriasis	1.46e-05	0.000113	CbGpPWpGaD
Fluphenazine—CALM2—Disease—CD4—psoriasis	1.46e-05	0.000113	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—NFKB1—psoriasis	1.46e-05	0.000113	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TYK2—psoriasis	1.43e-05	0.000111	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NFKBIA—psoriasis	1.43e-05	0.00011	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CAT—psoriasis	1.43e-05	0.00011	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CXCL8—psoriasis	1.42e-05	0.00011	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—JUN—psoriasis	1.42e-05	0.000109	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—JUN—psoriasis	1.42e-05	0.000109	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CXCL8—psoriasis	1.41e-05	0.000109	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—NFKB1—psoriasis	1.41e-05	0.000109	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TYK2—psoriasis	1.41e-05	0.000109	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TYK2—psoriasis	1.41e-05	0.000109	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—APOE—psoriasis	1.39e-05	0.000107	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NFKBIA—psoriasis	1.38e-05	0.000107	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NFKBIA—psoriasis	1.38e-05	0.000107	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—NFKB1—psoriasis	1.36e-05	0.000105	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—NFKB1—psoriasis	1.36e-05	0.000105	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—IL6—psoriasis	1.35e-05	0.000104	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—IL6—psoriasis	1.34e-05	0.000104	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—VEGFA—psoriasis	1.34e-05	0.000104	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—STAT3—psoriasis	1.33e-05	0.000103	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—VEGFA—psoriasis	1.32e-05	0.000102	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—JUN—psoriasis	1.32e-05	0.000102	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—JUN—psoriasis	1.31e-05	0.000101	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—STAT3—psoriasis	1.31e-05	0.000101	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—APOE—psoriasis	1.31e-05	0.000101	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TYK2—psoriasis	1.28e-05	9.9e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NFKB1—psoriasis	1.27e-05	9.81e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—STAT3—psoriasis	1.27e-05	9.78e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NFKB1—psoriasis	1.27e-05	9.76e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CXCL8—psoriasis	1.25e-05	9.63e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CXCL8—psoriasis	1.23e-05	9.47e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—STAT3—psoriasis	1.23e-05	9.46e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—STAT3—psoriasis	1.23e-05	9.46e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CXCL8—psoriasis	1.23e-05	9.45e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PPARG—psoriasis	1.21e-05	9.34e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—IL6—psoriasis	1.19e-05	9.16e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TP53—psoriasis	1.18e-05	9.09e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TYK2—psoriasis	1.17e-05	9.03e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—STAT3—psoriasis	1.17e-05	9.03e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—IL6—psoriasis	1.17e-05	9.01e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—IL6—psoriasis	1.16e-05	8.99e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—JUN—psoriasis	1.16e-05	8.95e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—VEGFA—psoriasis	1.15e-05	8.91e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—VEGFA—psoriasis	1.15e-05	8.86e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—STAT3—psoriasis	1.14e-05	8.82e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—JUN—psoriasis	1.14e-05	8.81e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PPARG—psoriasis	1.14e-05	8.8e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—JUN—psoriasis	1.14e-05	8.79e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—STAT3—psoriasis	1.14e-05	8.77e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TYK2—psoriasis	1.13e-05	8.74e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TYK2—psoriasis	1.13e-05	8.74e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—STAT3—psoriasis	1.13e-05	8.74e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—STAT3—psoriasis	1.13e-05	8.74e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	1.12e-05	8.62e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NFKB1—psoriasis	1.12e-05	8.62e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—APOE—psoriasis	1.11e-05	8.56e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NFKB1—psoriasis	1.1e-05	8.48e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NFKB1—psoriasis	1.1e-05	8.46e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IL6—psoriasis	1.08e-05	8.32e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL6—psoriasis	1.06e-05	8.2e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—JUN—psoriasis	1.04e-05	8.01e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CXCL8—psoriasis	1.02e-05	7.86e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—psoriasis	1.01e-05	7.83e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—psoriasis	1.01e-05	7.82e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—STAT3—psoriasis	1e-05	7.74e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—psoriasis	1e-05	7.72e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	1e-05	7.71e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—psoriasis	9.97e-06	7.69e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—psoriasis	9.95e-06	7.68e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—STAT3—psoriasis	9.87e-06	7.62e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CXCL8—psoriasis	9.86e-06	7.61e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CXCL8—psoriasis	9.86e-06	7.61e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—STAT3—psoriasis	9.85e-06	7.6e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6—psoriasis	9.69e-06	7.48e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PPARG—psoriasis	9.66e-06	7.46e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—JUN—psoriasis	9.47e-06	7.31e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6—psoriasis	9.37e-06	7.23e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6—psoriasis	9.37e-06	7.23e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6—psoriasis	9.28e-06	7.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—JUN—psoriasis	9.16e-06	7.07e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—JUN—psoriasis	9.16e-06	7.07e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6—psoriasis	9.16e-06	7.07e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NFKB1—psoriasis	9.12e-06	7.04e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	9.07e-06	7e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—STAT3—psoriasis	8.98e-06	6.93e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6—psoriasis	8.85e-06	6.83e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NFKB1—psoriasis	8.82e-06	6.81e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NFKB1—psoriasis	8.82e-06	6.81e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—psoriasis	8.72e-06	6.73e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—psoriasis	8.68e-06	6.7e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6—psoriasis	8.57e-06	6.61e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6—psoriasis	8.57e-06	6.61e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—psoriasis	8.28e-06	6.39e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—STAT3—psoriasis	8.2e-06	6.32e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6—psoriasis	8.17e-06	6.31e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—psoriasis	8.01e-06	6.18e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—psoriasis	8.01e-06	6.18e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6—psoriasis	7.98e-06	6.16e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6—psoriasis	7.94e-06	6.13e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—STAT3—psoriasis	7.93e-06	6.12e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—STAT3—psoriasis	7.93e-06	6.12e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6—psoriasis	7.91e-06	6.1e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6—psoriasis	7.91e-06	6.1e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—psoriasis	7.66e-06	5.91e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—psoriasis	7.53e-06	5.81e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—psoriasis	7.52e-06	5.8e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6—psoriasis	7.01e-06	5.41e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6—psoriasis	6.9e-06	5.32e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6—psoriasis	6.88e-06	5.31e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—psoriasis	6.85e-06	5.29e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6—psoriasis	6.27e-06	4.84e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—psoriasis	6.25e-06	4.83e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—psoriasis	6.05e-06	4.67e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—psoriasis	6.05e-06	4.67e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6—psoriasis	5.72e-06	4.42e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6—psoriasis	5.54e-06	4.27e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6—psoriasis	5.54e-06	4.27e-05	CbGpPWpGaD
